Joana Roxo

Joana Roxo is a Master student within the project "In vivo characterization of the impact of a novel rAAV gene therapy for LAMA2‑MD" (2026, 2027), under the supervision of Dr. Ana Rita Carlos from the Molecular Mechanisms of Disease (MMD) group of CE3C.